Johnson Matthey (OTCMKTS:JMPLY) has been assigned an average recommendation of “Hold” from the six analysts that are presently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a sell recommendation and three have issued a buy recommendation on the company.
A number of research firms have recently commented on JMPLY. Zacks Investment Research cut shares of Johnson Matthey from a “hold” rating to a “strong sell” rating in a report on Friday, July 19th. ValuEngine cut shares of Johnson Matthey from a “hold” rating to a “sell” rating in a report on Thursday, July 18th.
Shares of JMPLY stock remained flat at $$67.10 on Thursday. The company has a market cap of $6.49 billion, a price-to-earnings ratio of 11.26, a P/E/G ratio of 1.28 and a beta of 1.51. The company has a quick ratio of 1.00, a current ratio of 1.64 and a debt-to-equity ratio of 0.41. Johnson Matthey has a 12-month low of $66.88 and a 12-month high of $95.48. The stock has a 50-day moving average of $78.88 and a 200 day moving average of $81.87.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.